Interpretation of American Society of Hematology 2019 Guidelines for Immune Thrombocytopenia (the part for children)XU Yu-ting, HU Qun81-85
Interpretation of Updated International Consensus Report on the Investigation and Management of Primary Immune Thrombocytopenia (the part for children, Version 2019)XU Qian, ZHOU Min86-89,103
Research progress on the pathogenesis of pediatric immune thrombocytopeniaXIE Xing-juan, CHEN Zhen-ping90-94
Identifying primary immunodeficiencies in children with chronic immune thrombocytopeniaZHANG Jia-lu, WU Run-hui94-99
Quality of life of children with primary immune thrombocytopenia and its influencing factorsZHANG Heng, WEI Yu-ting, FANG Yong-jun99-103
Efficacy and safety of recombinant human thrombopoietin in the treatment of primary immune thrombocytopenia in children :A systematic review and meta-analysisLI Kun, YANG Yu-xian, CAO Bin104-109
Clinical features and gene analysis of three cases of immunodeficiency-centromeric instability-facial anomalies syndromeYANG Mi, SUN Bi-jun, WANG Wen-jie115-120
Interventional vascular complications in children with common congenital heart disease: A report of 4 casesLUO Gang, ZHAO Hong-wei, PAN Si-lin121-124
Alport syndrome with the onset of steroid-resistant nephrotic syndrome : A clinical analysis of 15 casesTAN Jun-jie, ZHANG Yao, YU Sheng-you125-129